Patients suffering with finger pain caused by Raynaud’s Syndrome are needed to participate in a clinical trial at Southern Illinois University School of Medicine’s Division of Plastic Surgery. The randomized, double-blind clinical trial examines the effect of using Botox® to relieve pain by increasing blood flow. SIU is the only site in the United States
Raynaud’s patients are being recruited for clinical trials of a new drug. Doctors seek study participants who: Are male or female between 18 and 65 years of age Have active Raynaud’s Phenomenon triggered by cold or stress Have at least 7 Raynaud’s attacks per week on 5 or more days per week
Dr. Vivien Hsu, Medical Director of Clinical Research Center at Robert Wood Johnson Medical School, will be speaking about upcoming clinical trials for scleroderma and Raynaud’s phenomenon patients on Saturday, November 13, 2010 1:00-3:00 p.m. at the Hackensack University Medical Center in New Jersey.